NOBILI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 160
EU - Europa 29
AS - Asia 26
SA - Sud America 1
Totale 216
Nazione #
US - Stati Uniti d'America 158
CN - Cina 12
FR - Francia 12
BG - Bulgaria 7
VN - Vietnam 6
IE - Irlanda 5
AE - Emirati Arabi Uniti 3
DE - Germania 3
CA - Canada 2
IN - India 2
JP - Giappone 2
CL - Cile 1
FI - Finlandia 1
IT - Italia 1
SG - Singapore 1
Totale 216
Città #
Fairfield 17
Seattle 17
Woodbridge 13
Buffalo 12
Santa Cruz 12
Ashburn 11
Houston 10
Columbus 9
Wilmington 8
Sofia 7
Dong Ket 6
Dublin 5
Beijing 3
Boardman 3
Cambridge 3
Paris 3
Ann Arbor 2
Bremen 2
New York 2
Ottawa 2
Atlanta 1
Austin 1
Bologna 1
Brockport 1
Chicago 1
Clearwater 1
Crugers 1
Guangzhou 1
Helsinki 1
Herndon 1
Los Angeles 1
Milpitas 1
Mountain View 1
Phoenix 1
Provo 1
San Francisco 1
Santa Clara 1
Santiago 1
Singapore 1
Totale 166
Nome #
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid, file e1dcb332-8a1f-7715-e053-1705fe0a6cc9 112
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study., file e1dcb333-7643-7715-e053-1705fe0a6cc9 74
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report, file e1dcb339-aee9-7715-e053-1705fe0a6cc9 28
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution, file f87a8da1-e348-4068-9e25-b66c438d2023 18
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor., file e1dcb331-6ea5-7715-e053-1705fe0a6cc9 1
Totale 233
Categoria #
all - tutte 652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202058 0 0 0 4 5 6 10 10 11 4 6 2
2020/202139 7 0 4 2 0 7 0 4 1 6 2 6
2021/202239 2 0 2 3 6 1 3 1 1 4 12 4
2022/202340 2 1 8 13 1 0 1 2 5 1 6 0
2023/202456 0 0 2 3 5 14 5 3 8 5 11 0
Totale 233